Joel Charrow

  • 6567 Citations
1978 …2019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

I have been practicing at Children's for more than 35 years, and continue to be clinically active, direct the Biochemical Genetics Lab, teach genetics to medical students, residents and fellows, and conduct research on genetic disorders. Board certified in Pediatrics, Clinical Genetics, and Clinical Biochemical Genetics. Professor of Pediatrics, Northwestern University Feinberg School of Medicine. Division Head, Genetics, Birth Defects and Metabolism.

Tay-Sachs disease and other gangliosidoses. Delineating the relationship between genetic abnormalities and specific phenotypes, with emphasis on the natural history of genetic disorders. Methods and pitfalls in population screening for genetic disorders. Natural history of neurofibromatosis-1 during childhood. Natural history and treatment of Gaucher disease and other lysosomal storage diseases.

Care of patients with inborn errors of metabolism and lysosomal storage disorders, Skeletal dysplasias, and Neurofibromatosis. Director, Biochemical Genetics Lab. Medical Director, Cytogenetics Lab.

Certifications and Licenses

Clinical Biochemical Genetics
Clinical Genetics (MD)

Training Experience

1977Internship, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital)
1979Residency, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital)
1981Fellowship, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital)

Education/Academic qualification

MD, Mount Sinai School of Medicine

… → 1976

Research interests

  • Genetics: Medical
  • Metabolism
  • Neurofibromatosis

Fingerprint Dive into the research topics where Joel Charrow is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Gaucher Disease Medicine & Life Sciences
Neurofibromatosis 1 Medicine & Life Sciences
Enzyme Replacement Therapy Medicine & Life Sciences
Fabry Disease Medicine & Life Sciences
Optic Nerve Glioma Medicine & Life Sciences
Registries Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Newborn Infant Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1978 2019

Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1

Mistry, P. K., Balwani, M., Baris, H. N., Turkia, H. B., Burrow, T. A., Charrow, J., Cox, G. F., Danda, S., Dragosky, M., Drelichman, G., El-Beshlawy, A., Fraga, C., Freisens, S., Gaemers, S., Hadjiev, E., Kishnani, P. S., Lukina, E., Maison-Blanche, P., Martins, A. M., Pastores, G. & 6 others, Petakov, M., Peterschmitt, M. J., Rosenbaum, H., Rosenbloom, B., Underhill, L. H. & Cox, T. M., Jul 1 2019, In : Blood Cells, Molecules, and Diseases. 77, p. 101-102 2 p.

Research output: Contribution to journalLetter

Gaucher Disease
1 Citation (Scopus)

Cervical spinal cord compression in infants with achondroplasia: should neuroimaging be routine?

Sanders, V. R., Sheldon, S. H. & Charrow, J., Feb 1 2019, In : Genetics in Medicine. 21, 2, p. 459-463 5 p.

Research output: Contribution to journalReview article

Spinal Cord Compression
Cervical Cord
Magnetic Resonance Imaging
6 Citations (Scopus)

C-type natriuretic peptide analogue therapy in children with achondroplasia

Savarirayan, R., Irving, M., Bacino, C. A., Bostwick, B., Charrow, J., Cormier-Daire, V., Le Quan Sang, K. H., Dickson, P., Harmatz, P., Phillips, J., Owen, N., Cherukuri, A., Jayaram, K., Jeha, G. S., Larimore, K., Chan, M. L., Labed, A. H., Day, J. & Hoover-fong, J., Jul 4 2019, In : New England Journal of Medicine. 381, 1, p. 25-35 11 p.

Research output: Contribution to journalArticle

C-Type Natriuretic Peptide
Plexiform Neurofibroma
Neurofibromatosis 1
Age Groups
1 Citation (Scopus)
Plexiform Neurofibroma
Neurofibromatosis 1
Nervous System Diseases
Information Systems
Quality of Life